Source: U.S. Food and Drug Administration From: CISON PR Newswire The U.S. Food and Drug Administration and the Nuclear Regulatory Commission (NRC) today took steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases. The FDA approved the RadioGenix System, a unique system for producing Technetium-99m (Tc-99m), the most widely …